Estrogen-induced upregulation and 3′-UTR shortening of CDC6

3′-Untranslated region (UTR) shortening of mRNAs via alternative polyadenylation (APA) has important ramifications for gene expression. By using proximal APA sites and switching to shorter 3′-UTRs, proliferating cells avoid miRNA-mediated repression. Such APA and 3′-UTR shortening events may explain the basis of some of the proto-oncogene activation cases observed in cancer cells. In this study, we investigated whether 17 β-estradiol (E2), a potent proliferation signal, induces APA and 3′-UTR shortening to activate proto-oncogenes in estrogen receptor positive (ER+) breast cancers. Our initial probe based screen of independent expression arrays suggested upregulation and 3′-UTR shortening of an essential regulator of DNA replication, CDC6 (cell division cycle 6), upon E2 treatment. We further confirmed the E2- and ER-dependent upregulation and 3′UTR shortening of CDC6, which lead to increased CDC6 protein levels and higher BrdU incorporation. Consequently, miRNA binding predictions and dual luciferase assays suggested that 3′-UTR shortening of CDC6 was a mechanism to avoid 3′-UTR-dependent negative regulations. Hence, we demonstrated CDC6 APA induction by the proliferative effect of E2 in ER+ cells and provided new insights into the complex regulation of APA. E2-induced APA is likely to be an important but previously overlooked mechanism of E2-responsive gene expression.

[1]  E. Levin,et al.  Integration of the extranuclear and nuclear actions of estrogen. , 2005, Molecular endocrinology.

[2]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[3]  David Haussler,et al.  The UCSC genome browser database: update 2007 , 2006, Nucleic Acids Res..

[4]  D. Gautheret,et al.  Conservation of alternative polyadenylation patterns in mammalian genes , 2006, BMC Genomics.

[5]  V. Scaria,et al.  MicroRNA-mediated up-regulation of an alternatively polyadenylated variant of the mouse cytoplasmic β-actin gene , 2008, Nucleic acids research.

[6]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[7]  H. Rochefort,et al.  Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Rogers,et al.  Two mRNAs with different 3′ ends encode membrane-bound and secreted forms of immunoglobulin μ chain , 1980, Cell.

[9]  V. Beneš,et al.  Transcriptional complexes engaged by apo-estrogen receptor-alpha isoforms have divergent outcomes. , 2004, The EMBO journal.

[10]  E. Wahle A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation , 1991, Cell.

[11]  Jeffrey Wilusz,et al.  The highways and byways of mRNA decay , 2007, Nature Reviews Molecular Cell Biology.

[12]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[13]  Joel S Parker,et al.  Extensive post-transcriptional regulation of microRNAs and its implications for cancer. , 2006, Genes & development.

[14]  D. Bartel,et al.  Weak Seed-Pairing Stability and High Target-Site Abundance Decrease the Proficiency of lsy-6 and Other miRNAs , 2011, Nature Structural &Molecular Biology.

[15]  R. Sutherland,et al.  Estrogen regulation of cell cycle progression in breast cancer cells 1 1 Proceedings of the 13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology “Recent Advances in Steroid Biochemistry & Molecular Biology” Monaco 25–28 May 1997. , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  Donny D. Licatalosi,et al.  RNA processing and its regulation: global insights into biological networks , 2010, Nature Reviews Genetics.

[17]  Elizabeth C. Theil,et al.  Multiple, Conserved Iron-responsive Elements in the 3′-Untranslated Region of Transferrin Receptor mRNA Enhance Binding of Iron Regulatory Protein 2* , 2002, The Journal of Biological Chemistry.

[18]  M. Hengartner,et al.  Analysis of C. elegans intestinal gene expression and polyadenylation by fluorescence-activated nuclei sorting and 3′-end-seq , 2012, Nucleic acids research.

[19]  E. Yaman,et al.  Unliganded estrogen receptor-alpha activates transcription of the mammary gland Na+/I- symporter gene. , 2006, Biochemical and biophysical research communications.

[20]  James B. Brown,et al.  Global patterns of tissue-specific alternative polyadenylation in Drosophila. , 2012, Cell reports.

[21]  V. Jordan,et al.  Treatment of Postmenopausal Breast Cancer with Selective Estrogen Receptor Modulators (SERMs). , 2005, Breast disease.

[22]  B. Tian,et al.  Alternative mRNA Polyadenylation Can Potentially Affect Detection of Gene Expression by Affymetrix GeneChip® Arrays , 2006, Applied bioinformatics.

[23]  Vladimir B. Bajic,et al.  Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes , 2003, Nucleic Acids Res..

[24]  Anindya Dutta,et al.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. , 2007, Genes & development.

[25]  L. Paillard,et al.  AU-rich elements and associated factors: are there unifying principles? , 2006, Nucleic acids research.

[26]  A. Kerstan,et al.  Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. , 1999, Immunity.

[27]  C. Lutz,et al.  Alternative mRNA polyadenylation in eukaryotes: an effective regulator of gene expression , 2011, Wiley interdisciplinary reviews. RNA.

[28]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[29]  P. Sharp,et al.  Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.

[30]  B. Geiger,et al.  Zebrafish cyclin D1 is differentially expressed during early embryogenesis. , 1995, Biochimica et biophysica acta.

[31]  G. Barton,et al.  Direct Sequencing of Arabidopsis thaliana RNA Reveals Patterns of Cleavage and Polyadenylation , 2012, Nature Structural &Molecular Biology.

[32]  L. Drury,et al.  Cdc6p-dependent loading of Mcm proteins onto pre-replicative chromatin in budding yeast. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Jie Yu,et al.  Two Estrogen Response Element Sequences Near the PCNA Gene Are Not Responsible for Its Estrogen-Enhanced Expression in MCF7 Cells , 2008, PloS one.

[34]  B. Hardesty,et al.  The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. , 1971, The Journal of biological chemistry.

[35]  C. Croce,et al.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Katzenellenbogen,et al.  Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells , 1999, Molecular and Cellular Endocrinology.

[37]  Maria Sjöberg,et al.  Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. , 2005, Molecular endocrinology.

[38]  Bin Tian,et al.  A large-scale analysis of mRNA polyadenylation of human and mouse genes , 2005, Nucleic acids research.

[39]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[40]  J. Nevins,et al.  Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[42]  David G Johnson,et al.  Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. , 2006, Current molecular medicine.

[43]  R. Agami,et al.  Tumorigenicity of the miR-17-92 cluster distilled. , 2010, Genes & development.

[44]  M. Pfaffl,et al.  Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR , 2006, Biotechnology Letters.

[45]  Denghui Xing,et al.  Alternative polyadenylation: a mechanism maximizing transcriptome diversity in higher eukaryotes. , 2009, Plant signaling & behavior.

[46]  R. Elkon,et al.  E2F mediates enhanced alternative polyadenylation in proliferation , 2012, Genome Biology.

[47]  William Ritchie,et al.  Differential Repression of Alternative Transcripts: A Screen for miRNA Targets , 2006, PLoS Comput. Biol..

[48]  S Audic,et al.  Alternate polyadenylation in human mRNAs: a large-scale analysis by EST clustering. , 1998, Genome research.

[49]  Michael Recce,et al.  PolyA_DB: a database for mammalian mRNA polyadenylation , 2004, Nucleic Acids Res..

[50]  Wenbin Ye,et al.  The Effect of Central Loops in miRNA:MRE Duplexes on the Efficiency of miRNA-Mediated Gene Regulation , 2008, PloS one.

[51]  Mark Gerstein,et al.  A genomic analysis of RNA polymerase II modification and chromatin architecture related to 3' end RNA polyadenylation. , 2008, Genome research.

[52]  Noah Spies,et al.  Biased chromatin signatures around polyadenylation sites and exons. , 2009, Molecular cell.

[53]  L. E. Faber,et al.  Estrogen and rapamycin effects on cell cycle progression in T47D breast cancer cells , 2001, Breast Cancer Research and Treatment.

[54]  J. Méndez,et al.  CDC6: from DNA replication to cell cycle checkpoints and oncogenesis. , 2008, Carcinogenesis.

[55]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[56]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[57]  F. Gebauer,et al.  Translational control by 3′-UTR-binding proteins , 2012, Briefings in functional genomics.

[58]  D. Bartel,et al.  Formation, Regulation and Evolution of Caenorhabditis elegans 3′UTRs , 2010, Nature.

[59]  A. E. Erson,et al.  USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers , 2010, Mammalian Genome.

[60]  Guoli Ji,et al.  Genome-wide landscape of polyadenylation in Arabidopsis provides evidence for extensive alternative polyadenylation , 2011, Proceedings of the National Academy of Sciences.

[61]  C. Klinge miRNAs and estrogen action , 2012, Trends in Endocrinology & Metabolism.

[62]  V. Jordan,et al.  Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. , 1992, Journal of the National Cancer Institute.

[63]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[64]  E. Wahle,et al.  Poly(A) Tail Length Is Controlled by the Nuclear Poly(A)-binding Protein Regulating the Interaction between Poly(A) Polymerase and the Cleavage and Polyadenylation Specificity Factor* , 2009, The Journal of Biological Chemistry.

[65]  D. Henley,et al.  Estrogens and cell-cycle regulation in breast cancer , 2001, Trends in Endocrinology & Metabolism.

[66]  J. Gustafsson,et al.  Estrogen receptor action. , 2002, Critical reviews in eukaryotic gene expression.

[67]  Yang Zhou,et al.  Effects of miR‐541 on neurite outgrowth during neuronal differentiation , 2011, Cell biochemistry and function.

[68]  David R. Setzer,et al.  Size heterogeneity in the 3′ end of dihydrofolate reductase messenger RNAs in mouse cells , 1980, Cell.

[69]  Mathieu Lupien,et al.  CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. , 2008, Cancer research.

[70]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[71]  P. Kapranov,et al.  Comprehensive Polyadenylation Site Maps in Yeast and Human Reveal Pervasive Alternative Polyadenylation , 2010, Cell.

[72]  Ryan J. Wagner,et al.  MicroRNA 92b Controls the G1/S Checkpoint Gene p57 in Human Embryonic Stem Cells , 2009, Stem cells.

[73]  D. Di Paola,et al.  Comparative analysis of pre‐replication complex proteins in transformed and normal cells , 2012, Journal of cellular biochemistry.

[74]  D. Agard,et al.  Estrogen receptor pathways to AP-1 , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[75]  P. Chambon,et al.  Structural and functional domains of the estrogen receptor. , 1986, Cold Spring Harbor symposia on quantitative biology.

[76]  Tyson A. Clark,et al.  Nova regulates brain-specific splicing to shape the synapse , 2005, Nature Genetics.

[77]  Mary Goldman,et al.  The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..

[78]  H. Auer,et al.  Expression Profiling Using Affymetrix GeneChip Microarrays. , 2009, Methods in molecular biology.

[79]  S. Leivonen,et al.  Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. , 2011, Cancer research.

[80]  Kristian Helin,et al.  Cell Cycle-Regulated Expression of MammalianCDC6 Is Dependent on E2F , 1998, Molecular and Cellular Biology.

[81]  Pieter J. De Bleser,et al.  ConTra v2: a tool to identify transcription factor binding sites across species, update 2011 , 2011, Nucleic Acids Res..

[82]  S. Baylin,et al.  Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. , 1995, Cancer research.

[83]  John H. White,et al.  Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells , 2007, Nucleic acids research.

[84]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[85]  Y. Sheen,et al.  Estrogen modulation of human breast cancer cell growth , 1997, Archives of pharmacal research.

[86]  Shuta Tomida,et al.  Reduced expression of Dicer associated with poor prognosis in lung cancer patients , 2005, Cancer science.

[87]  D Gautheret,et al.  Identification of alternate polyadenylation sites and analysis of their tissue distribution using EST data. , 2001, Genome research.

[88]  Sanghyuk Lee,et al.  MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.

[89]  S. Peltz,et al.  Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. , 1996, Annual review of biochemistry.

[90]  R. Young,et al.  Multiple polyadenylation sites in a mouse alpha-amylase gene. , 1981, Nucleic acids research.

[91]  C. Y. Chen,et al.  AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.

[92]  B. Cullen,et al.  Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. , 2003, Genes & development.

[93]  C. Klinge Estrogen receptor interaction with estrogen response elements. , 2001, Nucleic acids research.

[94]  Artemis G. Hatzigeorgiou,et al.  Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer , 2008, Proceedings of the National Academy of Sciences.

[95]  M. Dowsett,et al.  Combination therapy with aromatase inhibitors: the next era of breast cancer treatment? , 2006, British Journal of Cancer.

[96]  Bin Tian,et al.  A functional human Poly(A) site requires only a potent DSE and an A-rich upstream sequence , 2010, The EMBO journal.

[97]  H. Handa,et al.  Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3′-UTRs , 2006, Nucleic acids research.

[98]  Dennis B. Troup,et al.  NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..

[99]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[100]  Adrian Wiestner,et al.  Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. , 2007, Blood.

[101]  David Baltimore,et al.  Synthesis of secreted and membrane-bound immunoglobulin mu heavy chains is directed by mRNAs that differ at their 3′ ends , 1980, Cell.

[102]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[103]  Chong-Jian Chen,et al.  Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing. , 2011, Genome research.

[104]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[105]  V. Beneš,et al.  Transcriptional complexes engaged by apo‐estrogen receptor‐α isoforms have divergent outcomes , 2004 .

[106]  Peter A. Jones,et al.  Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. , 2006, Cancer cell.

[107]  M. Hentze,et al.  From cis-regulatory elements to complex RNPs and back. , 2012, Cold Spring Harbor perspectives in biology.

[108]  Eric T. Wang,et al.  Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.

[109]  Thomas D. Schmittgen,et al.  Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. , 2007, Cancer cell.

[110]  Ozlen Konu,et al.  Identification of endogenous reference genes for qRT-PCR analysis in normal matched breast tumor tissues. , 2009, Oncology research.

[111]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[112]  David P. Bartel,et al.  Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .

[113]  George A. Calin,et al.  A MicroRNA Signature of Hypoxia , 2006, Molecular and Cellular Biology.

[114]  B. Tian,et al.  Progressive lengthening of 3′ untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development , 2009, Proceedings of the National Academy of Sciences.

[115]  B. Meyers,et al.  Transcriptome dynamics through alternative polyadenylation in developmental and environmental responses in plants revealed by deep sequencing. , 2011, Genome research.

[116]  Margaret Gardiner-Garden,et al.  Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer , 2008, PloS one.

[117]  C. Lutz,et al.  Alternative polyadenylation: a twist on mRNA 3' end formation. , 2008, ACS chemical biology.

[118]  J. Yates,et al.  Molecular architecture of the human pre-mRNA 3' processing complex. , 2009, Molecular cell.

[119]  S. Vagner,et al.  Molecular mechanisms of eukaryotic pre-mRNA 3′ end processing regulation , 2009, Nucleic acids research.

[120]  P. Klatt,et al.  Oncogenic activity of Cdc6 through repression of the INK4/ARF locus , 2006, Nature.

[121]  Tyson A. Clark,et al.  HITS-CLIP yields genome-wide insights into brain alternative RNA processing , 2008, Nature.

[122]  Paolo Provero,et al.  Shortening of 3′UTRs Correlates with Poor Prognosis in Breast and Lung Cancer , 2012, PloS one.

[123]  J. Graber,et al.  Global changes in processing of mRNA 3' untranslated regions characterize clinically distinct cancer subtypes. , 2009, Cancer research.

[124]  Simion I. Chiosea,et al.  Overexpression of Dicer in precursor lesions of lung adenocarcinoma. , 2007, Cancer research.

[125]  C. Brokamp,et al.  Coordinated Post-transcriptional Regulation of Hsp70.3 Gene Expression by MicroRNA and Alternative Polyadenylation* , 2011, The Journal of Biological Chemistry.

[126]  K. Bystricky,et al.  Cell Cycle and Anti-Estrogen Effects Synergize to Regulate Cell Proliferation and ER Target Gene Expression , 2010, PloS one.

[127]  J. Thomsen,et al.  Mechanisms of estrogen action. , 2001, Physiological reviews.

[128]  S. Fuqua,et al.  Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling , 2010, Clinical Cancer Research.

[129]  B. Tian,et al.  Reprogramming of 3′ Untranslated Regions of mRNAs by Alternative Polyadenylation in Generation of Pluripotent Stem Cells from Different Cell Types , 2009, PloS one.

[130]  A. E. Erson,et al.  An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions. , 2009, Cancer genetics and cytogenetics.

[131]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[132]  E. Yaman,et al.  Unliganded estrogen receptor-α activates transcription of the mammary gland Na+/I− symporter gene , 2006 .

[133]  K. Nasmyth,et al.  An essential role for the Cdc6 protein in forming the pre-replicative complexes of budding yeast , 1996, Nature.

[134]  Simak Ali,et al.  Endocrine-responsive breast cancer and strategies for combating resistance , 2002, Nature Reviews Cancer.

[135]  J. Foekens,et al.  Tamoxifen resistance in breast cancer: elucidating mechanisms. , 2001, Drugs.

[136]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.